Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Crivera

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Medical Economics|September 26, 2015
Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel usersWilliam H Olson, Yi-Wen Ma, Concetta Crivera, et al.
Annals of Hematology|January 31, 2024
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximabIrina Murakhovskaya, Concetta Crivera, Ann Leon, et al.
Current Medical Research and Opinion|September 23, 2015
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measureColleen A McHorney, Concetta Crivera, François Laliberté, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosisAlok A Khorana, Keith R McCrae, Dejan Milentijevic, et al.
Journal of Occupational and Environmental Medicine|June 22, 2013
The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costsRobert L Page, Vahram Ghushchyan, Brian Gifford, et al.
Thrombosis Research|March 7, 2016
Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determinationHeather M Rozjabek, Craig I Coleman, Erin R Weeda, et al.
BMC Health Services Research|October 25, 2016
External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complicationsCraig I Coleman, W Frank Peacock, Gregory J Fermann, et al.
American Journal of Hematology|November 27, 2018
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulationAlok A Khorana, Keith McCrae, Dejan Milentijevic, et al.
Thrombosis Journal|March 16, 2016
External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approachesErin R Weeda, Christine G Kohn, Gregory J Fermann, et al.
American Journal of Hematology|February 4, 2018
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancerMichael B Streiff, Dejan Milentijevic, Keith McCrae, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Medical Economics|September 26, 2015
Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel usersWilliam H Olson, Yi-Wen Ma, Concetta Crivera, et al.
Annals of Hematology|January 31, 2024
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximabIrina Murakhovskaya, Concetta Crivera, Ann Leon, et al.
Current Medical Research and Opinion|September 23, 2015
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measureColleen A McHorney, Concetta Crivera, François Laliberté, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosisAlok A Khorana, Keith R McCrae, Dejan Milentijevic, et al.
Journal of Occupational and Environmental Medicine|June 22, 2013
The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costsRobert L Page, Vahram Ghushchyan, Brian Gifford, et al.
Thrombosis Research|March 7, 2016
Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determinationHeather M Rozjabek, Craig I Coleman, Erin R Weeda, et al.
BMC Health Services Research|October 25, 2016
External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complicationsCraig I Coleman, W Frank Peacock, Gregory J Fermann, et al.
American Journal of Hematology|November 27, 2018
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulationAlok A Khorana, Keith McCrae, Dejan Milentijevic, et al.
Thrombosis Journal|March 16, 2016
External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approachesErin R Weeda, Christine G Kohn, Gregory J Fermann, et al.
American Journal of Hematology|February 4, 2018
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancerMichael B Streiff, Dejan Milentijevic, Keith McCrae, et al.
Pageof 8